| Literature DB >> 35664858 |
Yifan Zhou1, Shuwen Gu1, Jie Li1, Peng Ji1, Yingjie Zhang1, Congcong Wu1, Qun Jiang1, Xiaojian Gao1, Xiaojun Zhang1.
Abstract
Non-O1/O139 Vibrio cholerae is a highly virulent pathogen that causes mass mortalities of various aquatic animals. In the present study, we sequenced the whole genome of non-O1/O139 V. cholerae GXFL1-4, isolated from Macrobrachium rosenbergii, to reveal the pathogenicity and antibiotic resistance. The result showed its genome contained two circular chromosomes and one plasmid with a total size of 4,282,243 bp, which harbored 3,869 coding genes. Among them, 3,047, 2,659, and 3,661 genes were annotated in the Clusters of Orthologous Genes (COG), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG), respectively. In addition, 372 potential virulence genes were predicted based on the Virulence Factor Database (VFDB) database, such as type II, III, IV, and VI secretion systems related genes, flagella genes, and pilus formation or motility-related genes. Blast results in the Comprehensive Antibiotic Resistance Database (CARD) database showed that the strain contained 148 antibiotic resistance-related genes belonging to 27 categories, such as efflux pump complex antibiotic resistance genes and antibiotic resistance gene cluster genes. The Pathogen-Host Interaction (PHI) database annotated 320 genes related to pathogen-host interaction, such as T3SS, virulence regulatory factors, transcriptional regulators, and two-component response regulator related genes. The whole-genome analysis suggested that the pathogenic non-O1/O139 V. cholerae strain GXFL1-4 might have a complex molecular mechanism of pathogenicity and antibiotic resistance. This study provides a wealth of information about non-O1/O139 V. cholerae genes related to its pathogenicity and drug resistance and will facilitate the understanding of its pathogenesis as well as the development of prevention and treatment strategies for the pathogen.Entities:
Keywords: antibiotic resistance-related genes; genomic characterization; non-O1/O139 Vibrio cholerae; secretion systems; virulence-related genes
Year: 2022 PMID: 35664858 PMCID: PMC9159153 DOI: 10.3389/fvets.2022.882885
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Genomic information for non-O1/O139 Vibrio cholerae strain GXFL1-4.
|
|
|
| |
|---|---|---|---|
| Size (bp) | 1,154,802 | 3,079,090 | 48,351 |
| C + G content (%) | 45.99 | 47.97 | 41.3 |
| CDS | 1,080 | 2,722 | 67 |
| Pseudogenes or gene fragments | 278 | 387 | 37 |
| Genes assigned to COGs | 758 | 2,282 | 7 |
| Average CDS length | 864.19 | 947.37 | 658.5 |
| rRNA genes | 0 | 31 | 0 |
| tRNA genes | 4 | 99 | 0 |
Figure 1Circular genome map of non-O1/O139 Vibrio cholerae GXFL1-4.
Figure 2The Clusters of Orthologous Genes (COG) functional annotation in the whole genome of non-O1/O139 V. cholerae strain GXFL1-4.
Figure 3Gene Oncology (GO) functional annotation in the whole genome of non-O1/O139 V. cholerae strain GXFL1-4.
Figure 4Gene distribution based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) classification of non-O1/O139 V. cholerae GXFL1-4.
The annotation of virulence factors of the strain GXFL1-4 in VFDB databases.
|
|
|
|
|---|---|---|
| Offensive virulence factors | Adherence | 42 |
| Offensive virulence factors | Invasion | 69 |
| Offensive virulence factors | Secretion system | 22 |
| Offensive virulence factors | Toxin | 10 |
| Defensive virulence factors | Antiphagocytosis | 13 |
| Defensive virulence factors | Serum resistance | 1 |
| Defensive virulence factors | Stress protein | 7 |
| Non-specific virulence factor | Iron uptake system | 3 |
| Regulation of virulence-associated genes | Regulation | 6 |
Antibiotic resistance of non-O1/O139 V. cholera GXFL1-4.
|
|
|
|
|---|---|---|
| Ampicillin | 10 | 0 (R) |
| Aztreonam | 30 | 9 ± 0.12 (R) |
| Cefazolin | 30 | 0 (R) |
| Cephalothin | 30 | 0 (R) |
| Cefuroxime | 30 | 0 (R) |
| Cefoperazone | 75 | 9 ± 0.14 (R) |
| Cefotaxime | 30 | 0 (R) |
| Ceftriaxone | 30 | 0 (R) |
| Cefepime | 30 | 0 (R) |
| Ceftazidime | 30 | 17 ± 0.15 (I) |
| Cefoxitin | 30 | 19 ± 0.12 (S) |
| Fleroxacin | 10 | 14 ± 0.14 (I) |
| Streptomycin | 10 | 15 ± 0.10 (S) |
| Tobramycin | 10 | 17 ± 0.11 (S) |
| Kanamycin | 30 | 14 ± 0.08 (I) |
| Midecamycin | 30 | 15 ± 0.09 (S) |
| Piperacillin | 100 | 0 (R) |
| Gentamicin | 10 | 18 ± 0.10 (S) |
| Penicillin | 10 | 0 (R) |
| Erythromycin | 15 | 22 ± 0.09 (S) |
| Spectinomyci | 100 | 22 ± 0.13 (S) |
| Clarithromycin | 15 | 17 ± 0.10 (I) |
| Clindamycim | 2 | 0 (R) |
| Chloramphenicol | 30 | 22 ± 0.11 (S) |
| Amikacin | 30 | 17 ± 0.10 (S) |
| Tetracycline | 30 | 21 ± 0.09 (S) |
| Minocycline | 30 | 23 ± 0.08 (S) |
| Nofloxacin | 10 | 13 ± 0.17 (I) |
| Ciprofloxacin | 2 | 16 ± 0.15 (I) |
| Levofloxacin | 5 | 13 ± 0.13 (R) |
| Polymyxin B | 300 | 13 ± 0.18 (S) |
| Paediatric Compound Sulfamethoxazole Tablets | 23.75 | 0 (R) |
| Nitrofurantoin | 300 | 0 (R) |
| Florfenicol | 5 | 21 ± 0.11 (S) |
| Enrofloxacin | 5 | 13 ± 0.19 (I) |
| Oxacillin | 1 | 0 (R) |
“S”, sensitive; “I”, intermediate; and “R”, resistance.
The antibiotic resistance genes of the strain GXFL1-4 annotated in CARD.
|
|
|
|
|---|---|---|
| pleuromutilin antibiotic | 8 |
|
| carbapenem | 11 |
|
| sulfonamide antibiotic | 2 |
|
| aminoglycoside antibiotic | 9 |
|
| macrolide antibiotic | 41 |
|
| glycopeptide antibiotic | 10 |
|
| tetracycline antibiotic | 38 |
|
| monobactam | 1 |
|
| diaminopyrimidine antibiotic | 3 |
|
| streptogramin antibiotic | 4 |
|
| glycylcycline | 1 |
|
| aminocoumarin antibiotic | 6 |
|
| cephamycin | 2 |
|
| penem | 3 |
|
| phenicol antibiotic | 9 |
|
| rifamycin antibiotic | 2 | |
| triclosan | 3 |
|
| acridine dye | 11 |
|
| peptide antibiotic | 15 |
|
| lincosamide antibiotic | 5 |
|
| fluoroquinolone antibiotic | 38 |
|
| nitroimidazole antibiotic | 1 |
|
| penam | 21 |
|
| cephalosporin | 3 |
|
| bicyclomycin | 3 |
|
| nucleoside antibiotic | 2 |
|
| oxazolidinone antibiotic | 4 |
|
Figure 5Statistical map of gene distribution in genomic islands.
Figure 6Pathogen-Host Interaction (PHI) phenotype mutation type distribution map.